TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study.

Marie José Kersten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.